Therapeutically-induced stable disease in oncology early clinical trials.

Francois MercierGeorgina Meneses-LorentePaul GrimseyAlex PhippsFrancesca Michielin

Published in: PloS one (2020)

Our analysis emphasizes the importance of collecting pre-baseline scans to distinguish therapeutically induced stable disease from cases where the tumor growth is not perturbed by treatment.

Keyphrases

clinical trial
high glucose
diabetic rats
computed tomography
palliative care
drug induced
randomized controlled trial
magnetic resonance imaging
oxidative stress
magnetic resonance
open label
replacement therapy
smoking cessation